Case File
efta-efta00885013DOJ Data Set 9OtherFrom: Jeffrey Epstein <[email protected]>
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00885013
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Jeffrey Epstein <[email protected]>
To: Jean Luc Brunel [email protected]>
Subject: Re: FW: <no subject>
Date: Mon, 26 Oct 2009 10:52:48 +0000
Andrew-- as you are aware the transaction can be structured in many ways. 1) Do you want the tax benefits?„
contract depreciation, etc. 2. ) do you want the possiblity of taking public later.- if so initial transaction needs
preparation. 3) do you want this to be the hub in a larger acqusitition strategy.. , i.e. do you want to buy other
agencies for paper.
On Mon, Oct 26, 2009 at 6:32 AM, Jean Luc Brunel <[email protected]> wrote:
Forwarded Message
From: Andrew Nikou
Date: Sun, 25 Oct 2009 11:07:22 -0700
To: jeanluc brunel <2jeanlucagmail.com>
Subject: RE: <no subject>
Hi Jean Luc,
Amazing last night! I have to tell you how my night ended!
Regarding your email. Lets talk next week. Would this assume that the new company does not take on the IRS liability?
Andrew
Andrew Nikou
Founder & Managing Partner
OpenGate Capital, LLC
1999 Avenue of the Stars I Suite 1830
Los Angeles I CA 190067
NMI
Office
Fax
US Mobile
I French Mobile
Save a tree. Please only print this e-mail if it is genuinely required.
From: Jean Luc Brunel imailto:2jeanlucegmail.corn]
Sent: Friday, October 23, 2009 3:06 PM
To: Andrew Nikou
Subject: <no subject>
Hi Andrew,
On an operating basis-yes, However, to recreatethe network,and current "assets ;it would take 2-3 years and more
money than that. The businesses usually are valued at one times revenue. Most recent sales have been a small multiple
of that. I am aware of the potential, as are you. If you prefer, we can structure it as a convertible preferred. I look
forward to hearing from you.
Best
Jean lUc
EFTA00885013
End of Forwarded Message
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments.
EFTA00885014
Technical Artifacts (4)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.